PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal

Shreya Kanodia, Eric Wieder, Sijie Lu et al. · 2010

Read PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal by Shreya Kanodia, Eric Wieder, Sijie Lu et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011770.txt.

Description

Shreya Kanodia and co-authors studied lasting remissions in chronic myelogenous leukaemia, in PLOS ONE in 2010. Interferon treatment produces complete cytogenetic remission in a minority of patients, and in a few the remission persists after the drug is stopped. Interferon partly works by raising killer T cells specific for a leukaemia peptide called PR1.

The team related those PR1-specific T cells to remissions maintained without further treatment. Their findings suggest immune guards keep the cancer down after interferon withdrawal. That link supports therapies that strengthen such T cells to hold leukaemia in check.

Catalog record

CREATORShreya Kanodia, Eric Wieder, Sijie Lu et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011770

Browse the full library · About the Tower of Babel